![Les secrets de management de Jean-Paul Clozel, l'homme qui a vendu sa biotech 30 milliards - Challenges Les secrets de management de Jean-Paul Clozel, l'homme qui a vendu sa biotech 30 milliards - Challenges](https://www.challenges.fr/assets/img/2018/04/11/cover-r4x3w1200-5acdf9bd5f246-img-4611.jpg)
Les secrets de management de Jean-Paul Clozel, l'homme qui a vendu sa biotech 30 milliards - Challenges
![Wirtschafts-Deal des Jahres - Der Mann, der es tat – Jean-Paul Clozel verkaufte seine Actelion: «Manchmal packt mich Wehmut» Wirtschafts-Deal des Jahres - Der Mann, der es tat – Jean-Paul Clozel verkaufte seine Actelion: «Manchmal packt mich Wehmut»](https://img.luzernerzeitung.ch/2020/10/7/e90ae494-5e69-4931-bf85-725ef96a4b8a.jpeg?width=560&fit=crop&quality=75&auto=webp&crop=1969,1109,x0,y623)
Wirtschafts-Deal des Jahres - Der Mann, der es tat – Jean-Paul Clozel verkaufte seine Actelion: «Manchmal packt mich Wehmut»
![Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (C) and Actelion CEO and founder Jean-Paul Clozel (R) attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (C) and Actelion CEO and founder Jean-Paul Clozel (R) attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd](https://c8.alamy.com/compfr/2cp63xg/johnson-johnson-chief-scientific-officer-pharmaceuticals-paul-stoffels-c-and-actelion-ceo-and-founder-jean-paul-clozel-r-attend-a-news-conference-at-actelion-headquarters-in-allschwil-switzerland-january-26-2017-reuters-arnd-wiegmann-2cp63xg.jpg)
Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (C) and Actelion CEO and founder Jean-Paul Clozel (R) attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd
Jean-Paul Clozel: "Il faut être prêt à se battre lorsqu'on pense que nos projets ont un sens" - rts.ch - Economie
Big Boss - Jean-Paul Clozel souhaite ouvrir l'horizon thérapeutique contre les troubles du sommeil grâce à un nouveau somnifère dont il aborde la recherche et les propriétés ainsi que l'homologation dans un
![15 photos et images de Actelion Ltd News Conference As Drugmaker Agrees 30 Takeover Billion With Johnson Johnson - Getty Images 15 photos et images de Actelion Ltd News Conference As Drugmaker Agrees 30 Takeover Billion With Johnson Johnson - Getty Images](https://media.gettyimages.com/id/632755468/fr/photo/paul-stoffels-chief-scientific-officer-of-johnson-johnson-left-jean-paul-clozel-co-founder-of.jpg?s=612x612&w=gi&k=20&c=r41gQy-nUDXHiOEQUrYU8pFpDp2TNdcCvpWqyUF9Tr0=)